Asthma affects over 260 million people worldwide with many unable to access essential inhaled treatments. World Asthma Day 2025 focuses on making these life-saving treatments accessible to everyone, everywhere. Physiopedia offers comprehensive resources to help rehabilitation professionals understand asthma management and advocate for better patient care.
World Asthma Day on 6 May 2025 brings attention to one of the most common chronic non-communicable diseases globally. This year’s theme “Make Inhaled Treatments Accessible for ALL” emphasises a crucial aspect of asthma management that impacts millions. Despite effective treatments being available, asthma still claims over 450,000 lives annually, with most asthma-related deaths occurring in low and lower-middle-income countries where access to inhaled corticosteroids remains limited.
Asthma attacks can be terrifying for sufferers and their carers, potentially resulting in hospitalisation and in some cases death. The distress caused by these attacks is largely preventable with appropriate treatment. Inhaled corticosteroid-containing medications address the underlying inflammation that causes asthma, significantly reducing the risk of attacks when used regularly.
Rehabilitation professionals play a vital role in asthma management beyond medication. Understanding proper inhaler technique, pulmonary rehabilitation principles and breathing exercises can substantially improve outcomes for people with asthma. Physiopedia offers extensive resources to support this understanding, including detailed pages on asthma pathophysiology, respiratory assessment and breathing retraining techniques.
The impact of inadequate treatment access extends beyond individual suffering. In many low and middle income countries, the high cost or limited availability of inhaled corticosteroids directly contributes to preventable deaths. Even in high income nations, financial barriers can prevent people from obtaining essential medications, resulting in poorly controlled symptoms and avoidable complications.
Healthcare professionals worldwide are urged to ensure evidence-based prescribing practices, including appropriate inhaled corticosteroid-containing medications alongside reliever treatments. Meanwhile, policy makers, governments and pharmaceutical companies must recognise the ongoing preventable morbidity and mortality associated with asthma and take action to improve access.
Rehabilitation professionals can contribute significantly to addressing this global health challenge by staying informed about best practices in asthma management, advocating for patient access to essential medications, and providing evidence-based interventions. Explore Physiopedia’s comprehensive asthma resources to enhance your clinical knowledge and join the global effort to make asthma treatment accessible for all.
Join the conversation on social media using #WorldAsthmaDay and #AsthmaAccessForAll to raise awareness about this critical global health issue.
Physiopedia Plus is a subscription site that offers internationally accredited continuing education and professional development opportunities for the global rehabilitation community in 6 languages.
Your subscription fees fund the Physiopedia charity website to keep it updated and openly accessible to all.
Your subscription also provides FREE access to Plus for rehabilitation professionals in low income countries.
There are also discounts available depending on where you live and for students.